Publication:
The Role of TNFR2 and DR3 in the In Vivo Expansion of Tregs in T Cell Depleting Transplantation Regimens.

dc.contributor.authorRodriguez-Barbosa, Jose-Ignacio
dc.contributor.authorSchneider, Pascal
dc.contributor.authorGraca, Luis
dc.contributor.authorBühler, Leo
dc.contributor.authorPerez-Simon, Jose-Antonio
dc.contributor.authorDel Rio, Maria-Luisa
dc.date.accessioned2024-10-23T13:07:20Z
dc.date.available2024-10-23T13:07:20Z
dc.date.issued2020-05-09
dc.description.abstractRegulatory T cells (Tregs) are essential for the maintenance of tolerance to self and non-self through cell-intrinsic and cell-extrinsic mechanisms. Peripheral Tregs survival and clonal expansion largely depend on IL-2 and access to co-stimulatory signals such as CD28. Engagement of tumor necrosis factor receptor (TNFR) superfamily members, in particular TNFR2 and DR3, contribute to promote peripheral Tregs expansion and sustain their survival. This property can be leveraged to enhance tolerance to allogeneic transplants by tipping the balance of Tregs over conventional T cells during the course of immune reconstitution. This is of particular interest in peri-transplant tolerance induction protocols in which T cell depletion is applied to reduce the frequency of alloreactive T cells or in conditioning regimens that allow allogeneic bone marrow transplantation. These conditioning regimens are being implemented to limit long-term side effects of continuous immunosuppression and facilitate the establishment of a state of donor-specific tolerance. Lymphopenia-induced homeostatic proliferation in response to cytoreductive conditioning is a window of opportunity to enhance preferential expansion of Tregs during homeostatic proliferation that can be potentiated by agonist stimulation of TNFR.
dc.format.number9es_ES
dc.format.volume21es_ES
dc.identifier.doi10.3390/ijms21093347
dc.identifier.e-issn1422-0067es_ES
dc.identifier.journalInternational journal of molecular scienceses_ES
dc.identifier.otherhttp://hdl.handle.net/10668/15549
dc.identifier.pubmedID32397343es_ES
dc.identifier.urihttps://hdl.handle.net/20.500.12105/25267
dc.language.isoeng
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectTNF/TNF receptors
dc.subjectGraft rejection
dc.subjectGraft-versus-host disease
dc.subjectHomeostatic proliferation
dc.subjectLymphopenia
dc.subjectRegulatory T cells
dc.subjectTransplantation
dc.subject.meshAbatacept
dc.subject.meshAdoptive Transfer
dc.subject.meshAllografts
dc.subject.meshAnimals
dc.subject.meshBone Marrow Transplantation
dc.subject.meshCell Differentiation
dc.subject.meshCell Division
dc.subject.meshGraft Rejection
dc.subject.meshHeart Transplantation
dc.subject.meshHomeostasis
dc.subject.meshHumans
dc.subject.meshImmune Tolerance
dc.subject.meshLymphocyte Depletion
dc.subject.meshLymphocyte Transfusion
dc.subject.meshLymphopenia
dc.subject.meshMice
dc.subject.meshModels, Immunological
dc.subject.meshReceptors, Tumor Necrosis Factor, Member 25
dc.subject.meshReceptors, Tumor Necrosis Factor, Type II
dc.subject.meshT-Lymphocytes, Regulatory
dc.subject.meshTransplantation Conditioning
dc.subject.meshTransplantation Immunology
dc.subject.meshTumor Necrosis Factor-alpha
dc.titleThe Role of TNFR2 and DR3 in the In Vivo Expansion of Tregs in T Cell Depleting Transplantation Regimens.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files